High Ki-67 expression is associated with prolactin secreting pituitary adenomas
Pituitary adenomas represent the third most common primary intracranial tumor in neurosurgical practice. To understand the biological behaviour of the pituitary adenomas previous studies have determined the tumor proliferation rate using monoclonal antibodies targeted against the Ki-67 antigen. The...
| Published in: | Biomolecules & Biomedicine |
|---|---|
| Main Authors: | Bogdan Bălinişteanu, Anca Maria Cîmpean, Amalia Raluca Ceauşu, Ana Silvia Corlan, Eugen Melnic, Marius Raica |
| Format: | Article |
| Language: | English |
| Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2017-05-01
|
| Subjects: | |
| Online Access: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/1750 |
Similar Items
Prediction of Higher Ki-67 Index in Pituitary Adenomas by Pre- and Intra-Operative Clinical Characteristics
by: Xuanzhi Wang, et al.
Published: (2022-07-01)
by: Xuanzhi Wang, et al.
Published: (2022-07-01)
Role of topoisomerase II α and Ki -67 biomarkers in pituitary tumors
by: Chhanda Das, et al.
Published: (2023-12-01)
by: Chhanda Das, et al.
Published: (2023-12-01)
A Dysregulation of the Prolactin/Vasoinhibin Axis Appears to Contribute to Preeclampsia
by: Livia Lenke, et al.
Published: (2020-01-01)
by: Livia Lenke, et al.
Published: (2020-01-01)
Expression of p53, Ki-67 and c-erb B2 in growth hormone-and/or prolactin-secreting pituitary adenomas Expressão de p53, Ki-67 e c-erb B2 em adenomas hipofisários secretores de prolactina e/ou hormônio de crescimento
by: Carlos Henrique A. Botelho, et al.
Published: (2006-03-01)
by: Carlos Henrique A. Botelho, et al.
Published: (2006-03-01)
Relationship between MRI features and HIF-1α, GLUT1 and Ki-67 expression in pituitary adenoma with cystic degeneration
by: Fangfang Zhang, et al.
Published: (2025-03-01)
by: Fangfang Zhang, et al.
Published: (2025-03-01)
Prognostic factors for surgical treatment of prolactin-secreting pituitary adenomas
by: Oleksandr Voznyak, et al.
Published: (2024-02-01)
by: Oleksandr Voznyak, et al.
Published: (2024-02-01)
Effects of prolactin on the proliferation and hormone secretion of ovine granulosa cells
by: Haiying He, et al.
Published: (2024-10-01)
by: Haiying He, et al.
Published: (2024-10-01)
Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment
by: Lukasz Dzialach, et al.
Published: (2024-02-01)
by: Lukasz Dzialach, et al.
Published: (2024-02-01)
The prolactin receptor gene (PRLR) is linked and associated with the risk of polycystic ovarian syndrome
by: Mutaz Amin, et al.
Published: (2023-11-01)
by: Mutaz Amin, et al.
Published: (2023-11-01)
Prognostic Factors for Invasiveness and Recurrence of Pituitary Adenomas: A Series of 94 Patients
by: Petros Stefanidis, et al.
Published: (2022-10-01)
by: Petros Stefanidis, et al.
Published: (2022-10-01)
Plasma prolactin axis shift from placental to pituitary origin in late prepartum mice
by: Taku James Sairenji, et al.
Published: (2024-07-01)
by: Taku James Sairenji, et al.
Published: (2024-07-01)
Study of Serum FSH, LH and Prolactin in Female Albino Rats by Experimentally Creating Hypothyroidism
by: Amber ILyas, et al.
Published: (2021-03-01)
by: Amber ILyas, et al.
Published: (2021-03-01)
Relation between vitamin D and adolescents’ serum prolactin
by: Ainur Amanzholkyzy, et al.
Published: (2023-12-01)
by: Ainur Amanzholkyzy, et al.
Published: (2023-12-01)
Immunohistochemical evaluation of BCL-2 and KI-67 proteins in colorectal adenoma.
by: Areege N. Abd, et al.
Published: (2014-07-01)
by: Areege N. Abd, et al.
Published: (2014-07-01)
Prolactin secreting pituitary neuroendocrine tumors treated by dopamine agonists: predictors of response
by: Chiara Mele, et al.
Published: (2025-09-01)
by: Chiara Mele, et al.
Published: (2025-09-01)
Associations of MEG3 rs7158663, rs4081134 gene variants and Ki-67, p53, CK18 immunohistochemical markers with clinical features of pituitary neuroendocrine tumors
by: Balys Remigijus Zaliunas, et al.
Published: (2025-10-01)
by: Balys Remigijus Zaliunas, et al.
Published: (2025-10-01)
Does altered Ki67 expression in recurrent membranous basal cell adenoma point toward the need for reclassification?
by: Dhinakaran Paranchodi, et al.
Published: (2024-09-01)
by: Dhinakaran Paranchodi, et al.
Published: (2024-09-01)
Pituitary adenoma: a literature review
by: A. Sidaraitė, et al.
Published: (2018-03-01)
by: A. Sidaraitė, et al.
Published: (2018-03-01)
Predictors of therapeutic failure in GH and prolactin co-secreting pituitary adenomas
by: Marta Araujo-Castro, et al.
Published: (2025-07-01)
by: Marta Araujo-Castro, et al.
Published: (2025-07-01)
Hyperprolactinemia caused by extra-pituitary prolactin secretion: a systematic review
by: Yixin Lu, et al.
Published: (2025-07-01)
by: Yixin Lu, et al.
Published: (2025-07-01)
Usefulness of prolactin levels in predicting the etiology of hyperprolactinemia in a cohort of 770 patients
by: Lucio Vilar, et al.
Published: (2024-09-01)
by: Lucio Vilar, et al.
Published: (2024-09-01)
Commentary: Prolactin Alters Blood Pressure by Modulating the Activity of Endothelial Nitric Oxide Synthase
by: Jakob Triebel, et al.
Published: (2017-05-01)
by: Jakob Triebel, et al.
Published: (2017-05-01)
Alterations of the Gut Microbiome in Patients With Pituitary Adenoma
by: Jinxian Hu, et al.
Published: (2022-08-01)
by: Jinxian Hu, et al.
Published: (2022-08-01)
Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients
by: Miriam da Costa OLIVEIRA, et al.
Published: (2020-01-01)
by: Miriam da Costa OLIVEIRA, et al.
Published: (2020-01-01)
Aggressive forms of pituitary adenomas (literature review and clinical observation)
by: P. L. Kalinin, et al.
Published: (2018-01-01)
by: P. L. Kalinin, et al.
Published: (2018-01-01)
Serrated adenoma of stomach: A premalignancy?
by: Divya Achutha Ail, et al.
Published: (2015-07-01)
by: Divya Achutha Ail, et al.
Published: (2015-07-01)
Caracterização clínica e imunoistoquímica dos adenomas clinicamente não-funcionantes de hipófise: clinical features and immunohistochemistry Non-functioning pituitary adenomas
by: Jane Eyre Alves Ferreira, et al.
Published: (2005-12-01)
by: Jane Eyre Alves Ferreira, et al.
Published: (2005-12-01)
A STUDY OF THE ROLE OF MICRORNA IN PITUITARY ADENOMA
by: I. F. Gareev, et al.
Published: (2018-07-01)
by: I. F. Gareev, et al.
Published: (2018-07-01)
Diagnosis and Treatment of Pituitary Adenomas
by: O. A. Beylerli, et al.
Published: (2020-01-01)
by: O. A. Beylerli, et al.
Published: (2020-01-01)
Difficulties in diagnosis of adenomas with mixed prolactin and growth hormone secretion: case presentation
by: Larisa K. Dzeranova, et al.
Published: (2020-12-01)
by: Larisa K. Dzeranova, et al.
Published: (2020-12-01)
A retrospective analysis of postoperative hypokalemia in pituitary adenomas after transsphenoidal surgery
by: Lili You, et al.
Published: (2017-05-01)
by: Lili You, et al.
Published: (2017-05-01)
A Non-Secreting Pituitary Adenoma That Changed to a Prolactinoma
by: Cristina Santiago-Vazquez, et al.
Published: (2024-07-01)
by: Cristina Santiago-Vazquez, et al.
Published: (2024-07-01)
Editorial: The metabolic effect of prolactin
by: Jesper Krogh
Published: (2023-05-01)
by: Jesper Krogh
Published: (2023-05-01)
The clinicopathological features of the pituitary adenoma and risk factors of recurrence
by: Yujia Yan, PhD, et al.
Published: (2022-01-01)
by: Yujia Yan, PhD, et al.
Published: (2022-01-01)
Clinicopathological profile of primary hyperparathyroidism with special reference to Ki-67 labelling index
by: Azhar S Thanveer, et al.
Published: (2023-01-01)
by: Azhar S Thanveer, et al.
Published: (2023-01-01)
Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness
by: Raghuveer Kavarthapu, et al.
Published: (2022-09-01)
by: Raghuveer Kavarthapu, et al.
Published: (2022-09-01)
Ectopic pituitary gland tumor in the clivus misdiagnosed as chordoma
by: Jin Mo Cho
Published: (2022-09-01)
by: Jin Mo Cho
Published: (2022-09-01)
Evaluation of Factors Affecting Outcome in Growth Hormone–Secreting Pituitary Adenomas
by: Amit Padwal, et al.
Published: (2017-09-01)
by: Amit Padwal, et al.
Published: (2017-09-01)
Comparative study on clinicopathological characteristics of functional and non-functional subtypes in pituitary adenomas
by: Ashish Ranjan Singh, et al.
Published: (2024-06-01)
by: Ashish Ranjan Singh, et al.
Published: (2024-06-01)
Treatment Outcome of Intensity-modulated Radiotherapy for 15 Patients with Giant Pituitary Adenoma
by: LIAN Xin, et al.
Published: (2022-01-01)
by: LIAN Xin, et al.
Published: (2022-01-01)
Similar Items
-
Prediction of Higher Ki-67 Index in Pituitary Adenomas by Pre- and Intra-Operative Clinical Characteristics
by: Xuanzhi Wang, et al.
Published: (2022-07-01) -
Role of topoisomerase II α and Ki -67 biomarkers in pituitary tumors
by: Chhanda Das, et al.
Published: (2023-12-01) -
A Dysregulation of the Prolactin/Vasoinhibin Axis Appears to Contribute to Preeclampsia
by: Livia Lenke, et al.
Published: (2020-01-01) -
Expression of p53, Ki-67 and c-erb B2 in growth hormone-and/or prolactin-secreting pituitary adenomas Expressão de p53, Ki-67 e c-erb B2 em adenomas hipofisários secretores de prolactina e/ou hormônio de crescimento
by: Carlos Henrique A. Botelho, et al.
Published: (2006-03-01) -
Relationship between MRI features and HIF-1α, GLUT1 and Ki-67 expression in pituitary adenoma with cystic degeneration
by: Fangfang Zhang, et al.
Published: (2025-03-01)
